Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Combination of a δ-opioid Receptor Agonist and Loperamide Produces Peripherally-mediated Analgesic Synergy in Mice
Bruce, D., Peterson, C. D., Kitto, K. F., Akgün, E., Lazzaroni, S., Portoghese, P. S., Fairbanks, C. A. & Wilcox, G. L., Sep 1 2019, In: Anesthesiology. 131, 3, p. 649-663 15 p.Research output: Contribution to journal › Article › peer-review
13 Scopus citations -
Combined Glia Inhibition and Opioid Receptor Agonism Afford Highly Potent Analgesics without Tolerance
Akgün, E., Lunzer, M. M. & Portoghese, P. S., Apr 17 2019, In: ACS Chemical Neuroscience. 10, 4, p. 2004-2011 8 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
Targeting MOR-mGluR5 heteromers reduces bone cancer pain by activating MOR and inhibiting mGluR5
Shueb, S. S., Erb, S. J., Lunzer, M. M., Speltz, R., Harding-Rose, C., Akgün, E., Simone, D. A. & Portoghese, P. S., Dec 1 2019, In: Neuropharmacology. 160, 107690.Research output: Contribution to journal › Article › peer-review
10 Scopus citations -
The bivalent ligand MCC22 potently attenuates hyperalgesia in a mouse model of cisplatin-evoked neuropathic pain without tolerance or reward
Cataldo, G., Erb, S. J., Lunzer, M. M., Luong, N., Akgün, E., Portoghese, P. S., Olson, J. K. & Simone, D. A., Nov 1 2019, In: Neuropharmacology. 158, 107598.Research output: Contribution to journal › Article › peer-review
14 Scopus citations -
A bivalent compound targeting CCR5 and the mu opioid receptor treats inflammatory arthritis pain in mice without inducing pharmacologic tolerance
Dutta, R., Lunzer, M. M., Auger, J. L., Akgün, E., Portoghese, P. S. & Binstadt, B. A., Jul 27 2018, In: Arthritis Research and Therapy. 20, 1, 154.Research output: Contribution to journal › Article › peer-review
Open Access21 Scopus citations